(Q34722518)

4 August 2017

1 reference

title

Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor (English)

1 reference

4 August 2017

1 reference

Razzetti R

1

1 reference

4 August 2017

Acerbi D

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

American Journal of Cardiology

4 August 2017

published in

1 reference

4 August 2017

volume

75

1 reference

4 August 2017

issue

18

1 reference

4 August 2017

page(s)

7F-12F

1 reference

Angiotensin-converting enzyme inhibitors: past, present, and bright future

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Therapeutic progress--review XXXIV. Congestive cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Medical advances in the treatment of congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Circulating and tissue angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Local generation and release of angiotensin II in peripheral vascular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Significance of vascular renin for local generation of angiotensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Direct proof for local generation and release of angiotensin II in peripheral human vascular tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

The myocardial renin-angiotensin system: existence, importance, and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Effect of delapril hydrochloride on angiotensin II release from isolated rat hind legs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

The antihypertensive mechanism of delapril, a newly developed converting enzyme inhibitor, is related to the suppression of vascular angiotensin II release in the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Effect of delapril on the vascular angiotensin II release in isolated hind legs of the spontaneously hypertensive rat: evidence for potential relevance of vascular angiotensin II to the maintenance of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Vascular wall renin in spontaneously hypertensive rats. Potential relevance to hypertension maintenance and antihypertensive effect of captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Cough associated with angiotensin converting enzyme inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Ramipril: review of pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

Characteristics of a new angiotensin converting enzyme inhibitor: delapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980508-6

10.1016/S0002-9149(99)80508-6

7 January 2021

Identifiers

DOI

1 reference

4 August 2017

1 reference